| abstract |
Provided is a compound having α4 integrin inhibitory action. n The compound is a sulfonamide derivative represented by the following formula (I), or pharmaceutically acceptable salt thereof: n nwhere R 1 to R 5 , e to h, D, and B represent those as described in the specification. |